• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The development of novel endodontic treatment using IL-1alpha/laminin for periapical periodontitis

Research Project

Project/Area Number 25861801
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Conservative dentistry
Research InstitutionOkayama University

Principal Investigator

Omori Kazuhiro  岡山大学, 大学病院, 講師 (20549860)

Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords歯内療法 / IL-1α / ラミニン / 根尖性歯周炎 / 歯内疾患 / 細胞外基質
Outline of Final Research Achievements

The precise periapical healing mechanism induced by root canal treatment (RCT) is unknown. We reported previously that interleukin (IL)-1a, but not IL-1b, and laminin were expressed during the healing phase in an experimental rat RCT model. However, the mechanism of the interaction between IL-1a and laminin for periapical healing is not clear. In this study, we investigated the biological effects of IL-1a and laminin on mouse osteoblastic cells, MC3T3-E1, and rat RCT model. IL-1a (0.1 ng/ml) and laminin (10 ng/ml) enhanced the phosphorylation of FAK and MAPKs (ERK1/2, p38, JNK1/2) in MC3T3-E1. In addition, IL-1a and laminin enhanced the mRNA expression of type1 collagen. We tried to visualize the inflammation of periapical region using molecular imaging. Inflammation of periapical region in rat RCT model was detected and quantified using molecular imaging. These data suggest that the dual effects of IL-1a and laminin may enhance the induction of osteogenesis during periapical healing.

Report

(4 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2014 Research-status Report
  • 2013 Research-status Report
  • Research Products

    (6 results)

All 2015 2014 2013

All Presentation (6 results)

  • [Presentation] 新たな糖尿病合併症に迫る ~糖尿病患者にとっての歯周病治療を再考する~2015

    • Author(s)
      大森一弘,髙柴正悟
    • Organizer
      第29回日本糖尿病合併症学会学術大会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-11-25
    • Related Report
      2015 Annual Research Report
  • [Presentation] 真菌由来代謝産物(+)-terreinはRANKL誘導性破骨細胞分化を抑制する2015

    • Author(s)
      中川沙紀,大森一弘,山本総司,小林寛也,後藤絢香,中村亜里紗,山本直史,髙柴正悟
    • Organizer
      第143回日本歯科保存学会秋季学術大会
    • Place of Presentation
      東京
    • Year and Date
      2015-11-12
    • Related Report
      2015 Annual Research Report
  • [Presentation] 真菌由来代謝産物(+)-terrein誘導体がIL-6誘導性VEGFおよびCSF-1の産生に及ぼす影響の検討2015

    • Author(s)
      山本総司,大森一弘,後藤絢香,池田淳史,小林寛也,中川沙紀,山本大介,山本直史,前田博史,髙柴正悟
    • Organizer
      第58回日本歯周病学会春季学術大会
    • Place of Presentation
      千葉
    • Year and Date
      2015-05-18
    • Related Report
      2015 Annual Research Report
  • [Presentation] 真菌由来代謝産物(+)-terreinはinterleukin-6誘導生colony stimulating factor-1の遺伝子発現を抑制する2014

    • Author(s)
      山本総司,大森一弘,後藤絢香,池田淳史,松永一幸,山本大介,山本直史,前田博史,髙柴正悟
    • Organizer
      第135回日本歯科保存学会秋季学術大会
    • Place of Presentation
      山形
    • Year and Date
      2014-10-31
    • Related Report
      2014 Research-status Report
  • [Presentation] IL-6/sIL-6Rは歯肉線維芽細胞から活性を有するリソソーム酵素カテプシンB,Lの分泌を亢進する2014

    • Author(s)
      後藤絢香,大森一弘,冨川知子,小林寛也,成石浩司,前田博史,髙柴正悟
    • Organizer
      第57回日本歯周病学会秋季学術大会
    • Place of Presentation
      神戸
    • Year and Date
      2014-10-18
    • Related Report
      2014 Research-status Report
  • [Presentation] 血管新生阻害物質terrein がヒト歯肉線維芽細胞におけるIL-6/sIL-6R誘導性angiogeninおよびVEGFの産生に及ぼす影響2013

    • Author(s)
      1. 山本大介,大森一弘,小林寛也,冨山高史,久保克行,成石浩司,前田博史,高柴正
    • Organizer
      第56回日本歯周病学会春季学術大会
    • Place of Presentation
      東京
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi